Converging Paths of Viral and Non-viral Vector Engineering
نویسندگان
چکیده
منابع مشابه
Engineering biomaterial systems to enhance viral vector gene delivery.
Integrating viral gene delivery with engineered biomaterials is a promising strategy to overcome a number of challenges associated with virus-mediated gene delivery, including inefficient delivery to specific cell types, limited tropism, spread of vectors to distant sites, and immune responses. Viral vectors can be combined with biomaterials either through encapsulation within the material or i...
متن کاملExpression and Purification of Human Interferon Gamma Using a Plant Viral Vector
A plant viral vector engineered from an in vivo infectious clone of zucchini yellow mosaic virus(ZYMV) was used to express the human interferon-gamma (INF-γ) in planta. The INF-γ gene was in frame inserted between the P1 and HC-Pro ORFs of the ZYMV vector. The infectious activity of the vector was approved by rubbing the plasmid on Chenopodium quino a and observing local lesions. Individual les...
متن کاملVector-Borne Viral Diseases
1 Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06512, USA 2Department of Biological Sciences, University of Southern Mississippi, Hattiesburg, MS 39406, USA 3Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China 4 Institute of Biology and Medical Sciences, Jiangsu Key Laboratory of Infection and Immunity, Soocho...
متن کاملEngineering influenza viral vectors
The influenza virus is a respiratory pathogen with a negative-sense, segmented RNA genome. Construction of recombinant influenza viruses in the laboratory was reported starting in the 1980s. Within a short period of time, pioneer researchers had devised methods that made it possible to construct influenza viral vectors from cDNA plasmid systems. Herein, we discuss the evolution of influenza vir...
متن کاملNovel Gene Therapy Viral Vector Using Non-Oncogenic Lymphotropic Herpesvirus
Despite the use of retroviral vectors, efficiently introducing target genes into immunocytes such as T cells is difficult. In addition, retroviral vectors carry risks associated with the oncogenicity of the native virus and the potential for introducing malignancy in recipients due to genetic carryover from immortalized cells used during vector production. To address these issues, we have estab...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Molecular Therapy
سال: 2008
ISSN: 1525-0016
DOI: 10.1038/sj.mt.6300378